This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

MRI Interventions To Exhibit Its ClearPoint Neuro Intervention System At AANS 2014 Annual Meeting

Stocks in this article: MRIC

IRVINE, Calif., April 3, 2014 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint ® Neuro Intervention System will be on exhibit at the 2014 Annual Meeting of the American Association of Neurological Surgeons (AANS) April 7-9, 2014, in San Francisco, California. Conference attendees are invited to visit the MRI Interventions booth (#1036) to explore an interactive presentation showing the ClearPoint system's unique capability to enable a wide range of neurosurgical applications under real-time MRI guidance.

The ClearPoint system's importance as a delivery platform for the investigational administration of Toca 511 will also be included in a presentation by Dr. Manish Aghi, neurosurgeon at the University of California, San Francisco (UCSF) on Monday, April 7, describing the ongoing Phase I investigational trial evaluating the safety and tolerability of Toca 511 in combination with Toca FC in recurrent high grade glioma patients.

Toca 511 is a retroviral replicating vector that carries a gene for an enzyme that converts orally delivered Toca FC (extended-release 5-FC) into 5-FU, a potent anticancer agent. During the Toca 511 delivery procedure, the ClearPoint system is used to merge neuronavigation with real-time MRI imaging, allowing visualization of adjustments to cannula trajectory, position and flow rate during the procedure.

The ClearPoint system's accuracy in the placement of drug delivery cannulas will also be presented in an e-poster titled "Direct Magnetic Resonance Imaging-guided placement of Convection Enhanced Delivery Cannula: Feasibility and Accuracy," authored by Prashant Chittiboina, M.D. and John D. Heiss, M.D., neurosurgeons at the National Institutes of Health, and Russell Lonser, M.D., neurosurgeon at the Ohio State University Wexner Medical Center. The presentation will review the accuracy of SmartFlow ® cannula placement with the ClearPoint system in three patients undergoing CED infusion for investigational treatment of diffuse intrinsic brainstem glioma or Parkinson's disease.

The ClearPoint system is the only navigation platform designed to allow real-time, direct visualization during minimally-invasive neurosurgical procedures. ClearPoint software works with MRI to assist surgeons in planning a target and trajectory, and the SmartFrame ® targeting device enables the MRI-guided alignment and insertion of surgical instruments. The ClearPoint system allows surgeons to monitor the placement of instruments and devices in the brain in real time for a growing range of neurosurgical procedures, including "asleep" deep brain stimulation electrode placement, focal laser ablation, brain biopsy, shunt placement and direct delivery of investigational therapeutic agents for treatment of brain tumors and Parkinson's disease.

About the ClearPoint System

The ClearPoint ® System is a navigation platform designed to allow real-time, direct visualization during minimally-invasive neurosurgical procedures. ClearPoint software works with MRI to assist surgeons in planning a target and trajectory, and the SmartFrame ® targeting device enables the MRI-guided alignment and insertion of surgical instruments.

The ClearPoint SmartFlow ® cannula is presently FDA-cleared for injection of cytarabine, a chemotherapy drug, to the ventricles or removal of CSF from the ventricles during intracranial procedures. Delivery of other therapeutic agents using the SmartFlow cannula is investigational.

About MRI Interventions, Inc.

Founded in 1998, MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart. Utilizing a hospital's existing MRI suite, the company's FDA-cleared and CE-marked ClearPoint ® system is designed to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, MRI Interventions is developing the ClearTrace ® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation. Building on the imaging power of MRI, the company's interventional platforms strive to improve patient care while reducing procedure costs and times. For more information, please visit www.mriinterventions.com .

CONTACT: David Carlson
         Chief Financial Officer
         MRI Interventions, Inc.
         901-522-9300

MRI Interventions, Inc. logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs